Opsidio - Crunchbase Company Profile & Funding

Q: Who invested in Opsidio?

Opsidio has 2 investors including Mid Atlantic Bio Angels And BioAdvance.

Q: When was the last funding round for Opsidio?

Opsidio closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Opsidio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Opsidio

CB Rank

173313

Opsidio is a biotechnology company that develops novel biologic therapeutics for patients suffering from fibrotic and allergic diseases.

Founded

obfuscation

Private

Venture - Series Unknown

Bryn Mawr, Pennsylvania, United States

1-10

www.opsidio.com/

Biotechnology

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

John Oates: COO and CFO
Nicholas Lukacs: Co-Founder & CSO

Details

Legal Name

Opsidio, LLC

Operating Status

Active

Company Type

For Profit

Founders

Martin Phillips, Nicholas Lukacs, Steven Kunkel

About the Company

A biotech company, engages in developing monoclonal antibodies to treat fibrotic and remodeling diseases. The company was founded in 2012 and is headquartered in Bryn Mawr, Pennsylvania .

Phone Number

(484) 557-0698

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

OpSCF Monoclonal Antibody

A monoclonal antibody targeting Stem Cell Factor (SCF) to reduce pulmonary fibrosis and allergic airway remodeling.

Anti-KITLG Therapy (aKITL)

An antibody therapy targeting KIT Ligand (KITLG) to reduce renal fibrosis and kidney damage in chronic kidney disease models.

Research & Development

Opsidio is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Opsidio	2	obfuscated obfuscation	BioAdvance	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Mid Atlantic Bio Angels	—	Venture Round - Opsidio	—
Mid Atlantic Bio Angels	—	Venture Round - Opsidio	—
Mid Atlantic Bio Angels	—	Venture Round - Opsidio	—
Mid Atlantic Bio Angels	—	Venture Round - Opsidio	—
Mid Atlantic Bio Angels	—	Venture Round - Opsidio	—